Cellular Dynamics International Receives $30,000,000 Series B Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4d33a96e-87e9-4ed2-a412-93108eb1cdb5&Preview=1
Date 4/7/2011
Company Name Cellular Dynamics International
Mailing Address 525 Science Drive Madison, WI 53711
Company Description Cellular Dynamics was founded by three world-class scientists in cardiac ion channel models, hES cells, and iPS cells to provide cardiac toxicity drug testing services, including GLP and non-GLP hERG electrophysiological assays as well as action potential and cytotoxicity screens using hES-cell derived cardiomycytes.
Proceeds Purposes This financing enables the company to launch new iCellĀ® iPSC lines as well as iCell Endothelial Cells, iCell Neurons, and iCell Hepatocytes lines for biomedical and pharmaceutical drug development and safety research, as well as continue to increase production capacity for its iCell Cardiomyocytes. CDI also plans to continue to rapidly expand its commercial organization to meet the growing demand for these iPSC-based products.